PRIA Logo™
117-hr-8540117th Congress

Developing and Nationalizing Key Cannabis Research Act of 2022

Sponsored By: Representative Peters, Scott H. [D-CA-50]

Unknown

Summary

Developing and Nationalizing Key Cannabis Research Act of 2022 This bill directs the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to expand activities concerning cannabis research. The NIH must collaborate with specified agencies to develop a national cannabis research agenda. Among other topics, the agenda must address (1) the therapeutic benefits of cannabis, (2) how cannabis effects specified populations, and (3) other public safety considerations. Additionally, the NIH must designate centers of excellence in cannabis research at institutions of higher education to conduct interdisciplinary research about biomedical, behavioral, and social issues related to cannabis. The CDC must work with other agencies to collect population-wide data about cannabis use, including (1) demographic factors, (2) health outcomes, (3) product variety, and (4) other relevant health information.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Peters, Scott H. [D-CA-50]

CA • D

Cosponsors

  • Rep. Joyce, David P. [R-OH-14]

    OH • R

    Sponsored 7/27/2022

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation